These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7893275)

  • 1. Quality of cefotaxime sodium preparations.
    Wetterich U; Mutschler E
    Arzneimittelforschung; 1995 Jan; 45(1):74-80. PubMed ID: 7893275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the color stability and impurity profile of cefotaxime sodium.
    Sun H; Cui X; Liu B; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():235-244. PubMed ID: 28890363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual degradation rate constants for cefotaxime, deacetylation profile.
    Fabre H; Blanchin MD; Mandrou B; Bergé G
    Farmaco; 1989; 44(7-8):695-702. PubMed ID: 2590367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Critical Review of Analytical Methods for Quantification of Cefotaxime.
    Consortti LP; Salgado HRN
    Crit Rev Anal Chem; 2017 Jul; 47(4):359-371. PubMed ID: 28287269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological Changes in Ovary Treated with Dexamethasone and Cefotaxime Sodium.
    Omairi S; Alyodawi K; Al Qaisi T
    Arch Razi Inst; 2022 Jun; 77(3):999-1005. PubMed ID: 36618313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled hydrolysis of ceftiofur sodium, a broad-spectrum cephalosporin; isolation and identification of hydrolysis products.
    Koshy KT; Cazers AR
    J Pharm Sci; 1997 Mar; 86(3):389-95. PubMed ID: 9050811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and genotoxic profile of a dimeric impurity of cefotaxime.
    Agarwal SK; Bhatnagar U; Rajesh N
    Int J Toxicol; 2004; 23(1):41-5. PubMed ID: 15162846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cefotaxime in two peritoneal dialysis solutions.
    Paap CM; Nahata MC
    Am J Hosp Pharm; 1990 Jan; 47(1):147-50. PubMed ID: 2301423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibilities to acylate 7-aminocephalosporanic acid to obtain some cephalosporins.
    Stan CD; Drăgan M; Diaconu DE; Stefanache A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):244-9. PubMed ID: 24741808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assay of cefotaxime and desacetylcefotaxime in plasma and urine by high performance liquid chromatography].
    Demotes-Mainard F; Vinçon G; Bouchet JL; Jarry C; Albin H
    Ann Biol Clin (Paris); 1984; 42(4):301-5. PubMed ID: 6093635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method to identify products induced by radiosterilization. A study of cefotaxime sodium.
    Crucq AS; Tilquin B
    J Pharm Belg; 1996; 51(6):285-8. PubMed ID: 9014401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrophotometric complexation of cephalosporins with palladium (II) chloride in aqueous and non-aqueous solvents.
    Bagheri Gh A; Yosefi rad A; Rezvani M; Roshanzamir S
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Apr; 89():317-21. PubMed ID: 22286057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)].
    Kasai Y; Nakanishi M; Sawada Y; Nakamura T; Hashimoto I; Mikami J; Bekki E; Hirasawa S; Abe H; Kasai K; Omosu M
    Jpn J Antibiot; 1981 Mar; 34(3):447-52. PubMed ID: 6270392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.
    Foley PT; Bosso JA; Bair JN; Townsend RJ
    Am J Hosp Pharm; 1985 Apr; 42(4):839-43. PubMed ID: 4014236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of cefotaxime sodium versus a combination of cefapirin and gentamicin in the prophylactic treatment of patients undergoing cholecystectomy.
    Ker CG; Hou MF; Chen JS; Lee KT; Sheen PC; Akbary MA
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):711-5. PubMed ID: 2695726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.